Randomized Trial of Short-Course High-Dose Erythropoietin in Donation After Cardiac Death Kidney Transplant Recipients

American Journal of Transplantation, 04/18/2012

Results showed no differences in the incidence or duration of delayed graft function and/or primary nonfunction. Epoetin treatment significantly increased the risk of thrombotic events at 1 month and 1 year.

Print Article Summary Cat 2 CME Report